PRESS-RELEASE ·Filed Aug 20, 2026
Press release: m_and_a
Actionable Insight • Neutral
Filing ingested — full details in report page.
Latest settled — T+20d
REGN ▼ -5.06% at T+20d
NEUTRAL call ✗ call lost -5.06% · α vs SPY -5.06% · entry $826.64 → $784.85
Latest observation: T+27 -22.21% FF3 residual α
T+1d
+0.90%
call +0.90% · α +0.49%
$834.04
settled 6w ago
T+5d
-2.29%
call -2.29% · α -3.40%
$807.71
settled 5w ago
T+20d
-5.06%
call -5.06% · α -5.06%
$784.85
settled 15d ago
T+60d
—
call — · α —
—
in 6w
Price Chart
Loading chart...
Executive Summary
No summary provided
Financial Impact
Not specified
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (37 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302855747 |
26 reports for REGN
85% Hit rate best @ T+60▲ +26.47%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 1d ago | ANALYST-UPGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | Insider Cluster | $843.47 $781.49 | ▼ −7.35% | ▼ −6.20% | $735.20 (−12.84%) |
Aug 24, 2026 5w ago | Court Ruling | $828.50 $799.08 | ▼ −3.55% | ▼ −4.02% | $735.20 (−11.26%) |
Aug 20, 2026 6w ago | Press Release | $826.64 $807.71 | ▼ −2.29% | ▼ −3.40% | $735.20 (−11.06%) |
Aug 12, 2026 7w ago | Insider Cluster | $797.99 $840.84 | ▲ +5.37% | ▲ +5.81% | $735.20 (−7.87%) |
Aug 11, 2026 7w ago | Court Ruling | $797.00 $807.57 | ▲ +1.33% | ▲ +1.73% | $735.20 (−7.75%) |
Jul 30, 2026 9w ago | 8-K | $738.34 $772.11 | ▲ +4.57% | ▲ +0.95% | $735.20 (−0.43%) |
Jul 30, 2026 9w ago | Press Release | $738.34 $772.11 | ▲ +4.57% | ▲ +0.95% | $735.20 (−0.43%) |
Jul 27, 2026 9w ago | Press Release | $695.18 $759.24 | ▼ −9.21% | ▼ −6.95% | $735.20 (−5.76%) |
Jul 17, 2026 11w ago | Press Release | $676.69 $651.91 | ▼ −3.66% | ▼ −2.97% | $735.20 (+8.65%) |
Showing 10 of 26
US Market Status
Market Closed — Opens Mon (65h 9m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access